High incidence of venous thromboembolism despite electronic alerts for thromboprophylaxis in hospitalised cancer patients

Thrombosis and Haemostasis

Volumn 110, Issue 1, 2013, Pages 184-190

  Lecumberri, Ramón ^a   Marqués, Margarita ^a   Panizo, Elena ^a   Alfonso, Ana ^a   García Mouriz, Alberto ^a   Gil Bazo, Ignacio ^a   Hermida, José ^b   Schulman, Sam ^c   Páramo, José A ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

Cancer; Electronic alerts; Hospitalised patients; Prophylaxis; Venous thromboembolism

Indexed keywords

BEMIPARIN; ENOXAPARIN;

ADULT; ARTICLE; CANCER PATIENT; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; ECHOGRAPHY; ELECTRONIC ALERT; FEMALE; HOSPITAL PATIENT; HUMAN; INCIDENCE; INTERMITTENT PNEUMATIC COMPRESSION DEVICE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; RECOMMENDED DRUG DOSE; THROMBOSIS; VENOUS THROMBOEMBOLISM;

ADULT; AGED; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HOSPITALIZATION; HOSPITALS, UNIVERSITY; HUMANS; INCIDENCE; MALE; MEDICAL ORDER ENTRY SYSTEMS; MIDDLE AGED; NEOPLASMS; QUALITY IMPROVEMENT; SOFTWARE; VENOUS THROMBOEMBOLISM;

EID: 84879623976     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH13-02-0131     Document Type: Article

References (35)

1. Cohen AT, Agnelli G, Anderson FA, et al. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost 2007; 98: 756-764.
2. Dunn AS, Brenner A, Halm EA. The magnitude of an iatrogenic disorder: a systematic review of the incidence of venous thromboembolism for general medical inpatients. Thromb Haemost 2006; 95: 758-762.
3. Sousou T, Khorana AA. New insights into cancer-associated thrombosis. Arterioscler Thromb Vasc Biol 2009; 29: 316-320.
4. Khorana AA, Francis CW, Culakova E, et al. Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients. Cancer 2007; 110: 2339-2346.
5. Khorana AA, Francis CW, Culakova E, et al. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost 2007; 5: 632-634.
6. Chew HK, Wun T, Harvey D, et al. Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med 2006; 166: 458-464.
7. Dentali F, Douketis JD, Gianni M, et al. Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients. Ann Intern Med 2007; 146: 278-288.
8. Lloyd NS, Douketis JD, Moinuddin I, et al. Anticoagulant prophylaxis to prevent asymptomatic deep vein thrombosis in hospitalized medical patients: a systematic review and meta-analysis. J Thromb Haemost 2008; 6: 405-414.
9. Kahn SR, Lim W, Dunn AS, et al. Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (2 Suppl): e195S-e226S.
10. Tapson VF, Decousus H, Pini M, et al. Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism. Chest 2007; 132: 936-945.
11. Cohen AT, Tapson VF, Bergmann JF, et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet 2008; 371: 387-394.
12. Amin AN, Lin J, Thompson S, et al. Real-world rates of in-hospital and postdischarge deep-vein thrombosis and pulmonary embolism in at-risk medical patients in the United States. Clin Appl Thromb Hemost 2011; 17: 611-619.
13. Kucher N, Koo S, Quiroz R, et al. Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med 2005; 352: 969-977.
14. Lecumberri R, Marqués M, Díaz-Navarlaz MT, et al. Maintained effectiveness of an electronic alert system to prevent venous thromboembolism among hospitalized patients. Thromb Haemost 2008; 100: 699-704.
15. Kucher N, Puck M, Blaser J, et al. Physician compliance with advanced electronic alerts for preventing venous thromboembolism among hospitalized medical patients. J Thromb Haemost 2009; 7:1 291-296.
16. Beeler PE, Kucher N, Blaser J. Sustained impact of electronic alerts on rate of prophylaxis against venous thromboembolism. Thromb Haemost 2011; 106: 734-738.
17. Lecumberri R, Panizo E, Gomez-Guiu A, et al. Economic impact of an electronic alert system to prevent venous thromboembolism in hospitalised patients. J Thromb Haemost 2011; 9: 1108-1115.
18. Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126 (3 Suppl): 338S-400S.
19. Alonso C, Medrano FJ, Romero A, et al. Guía PRETEMED 2003. Guía de profilaxis de enfermedad tromboembólica en patología médica. SADEMI, Córdoba; 2003. ISBN: 84-699-8538-8 (84-699-8537-X).
20. Ministerio de Sanidad, Servicios Sociales e Igualdad. Clasificación internacional de Enfermedades, 9a revisión, Modificación Clínica. Madrid. Ediciones 2004, 2006, 2008, 2010.
21. 3M Health Information Systems 575 West Murray Boulevard Salt Lake City, UT 84123, USA. Available at: www.3Mhis.com
22. Amin AN, Deitelzweig SB. Optimising the prevention of venous thromboembolism: recent quality initiatives and strategies to drive improvement. Jt Comm J Qual Patient Saf 2009; 35: 558-564.
23. Monreal M, Falgá C, Valdés M, et al. Fatal pulmonary embolism and fatal bleeding in cancer patients with venous thromboembolism: findings from the RIETE registry. J Thromb Haemost. 2006; 4: 1950-1956.
24. Fiumara K, Piovella C, Hurwitz S, et al. Multi-screen electronic alerts to augment venous thromboembolism prophylaxis. Thromb Haemost 2010; 103: 312-317.
25. Kucher N, Spirk D, Baumgartner I, et al. Lack of prophylaxis before the onset of acute venous thromboembolism among hospitalized cancer patients: the SWIss Venous ThromboEmbolism Registry (SWIVTER). Ann Oncol 2010; 21: 931-935.
26. Agnelli G, George DJ, Kakkar AK, et al. Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer. N Engl J Med 2012; 366: 601-609.
27. Hull RD, Schellong SM, Tapson VF, et al. Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial. Ann Intern Med 2010; 153: 8-18.
28. Leizorovicz A, Cohen AT, Turpie AG, et al. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation 2004; 110: 874-879.
29. Ageno W. Do medical patients need to receive pharmacologic prophylaxis for the prevention of venous thromboembolism? Intern Emerg Med 2012; 7 (Suppl 3): S189-192.
30. Prandoni P, Lensing AW, Piccioli A, et al. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 2002; 100: 3484-3488.
31. Imberti D, Prisco D. Venous thromboembolism prophylaxis in medical patients: future perspectives. Thromb Res 2005; 116: 365-375.
32. Lyman GH, Khorana AA, Falanga A, et al. American Society of Clinical Oncology. American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. J Clin Oncol 2007; 25: 5490-5505.
33. Schulman S. Thromboprophylaxis in medical patients - why not for all? Pathophysiol Haemost Thromb 2006; 35: 141-145.
34. Decousus H, Tapson VF, Bergmann JF, et al. Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators. Chest 2011; 139: 69-79.
35. Goldhaber SZ. Outpatient venous thromboembolism: the importance of optimum prophylaxis. Nat Clin Pract Cardiovasc Med 2008; 5: 12-13.